Skip to main content

Algen Biotechnologies

October 17, 2023
Franciscan D
Platform for Therapeutics
Algen is a platform therapeutics and drug discovery company using the world's leading CRISPR and AI to uncover disease-driving RNA messages to find treatments for cancer, inflammation and other diseases. Spun out from Nobel Laureate Professor Jennifer Doudna's Lab, Algen aims to develop the world's smartest drug discovery decision platform and data universe to create next-generation therapeutics. Algen has its internal drug development pipeline and partners with a number of leading pharmaceutical companies on its flagship next-generation CRISPR-based platform.
Chun-Hao Huang, CEO & Co-Founder - Algen Biotechnologies